AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CHLORURE DE DEQUALINIUM
4 registrations across 3 African markets— 4 active
Markets with CHLORURE DE DEQUALINIUM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FLUOMIZIN 10MG COMPRIME VAGINAL BOITE DE 6 | 🇨🇮Côte d'Ivoire | DAFRA PHARMA GMBH | active | — |
| FLUOMIZIN® 10MG CP VAG BTE(1 X 6) DAFRA PHARMA Comprimé vaginal, boîte de 6 | 🇲🇬Madagascar | DAFRA PHARMA GmbH | active | — |
| FLUOMIZIN® 10MG CP VAG BTE(1 X 6) DAFRA PHARMA Comprimé vaginal, boîte de 6 | 🇲🇬Madagascar | DAFRA PHARMA GmbH | active | — |
| FLUOMIZIN ovule / 10 mg | 🇸🇳Senegal | DAFRA PHARMA GMBH | active | — |
CHLORURE DE DEQUALINIUM in Africa — Regulatory Overview
CHLORURE DE DEQUALINIUM is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.